EDQM conducts GMP inspection of SMS Pharmaceuticals Ltd's API facility

The European Directorate for the Quality of Medicines & HealthCare (EDQM) conducted a GMP inspection of SMS Pharmaceuticals Limited's Active Pharmaceutical Ingredient(API) manufacturing facility located at Vizianagaram, Andhra Pradesh from 28th February, 2024 to 01st March, 2024 and inspection is successful, the report is awaited.

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 147.15 as compared to the previous close of Rs. 149.75. The total number of shares traded during the day was 19386 in over 777 trades.

The stock hit an intraday high of Rs. 156.90 and intraday low of 146.00. The net turnover during the day was Rs. 2917878.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals INE812G01025 EDQM GMPInspection APIFacility